Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 6 of 6 for “"Deferiprone (DFP)"”.
-
A novel role for SENP3 in iron-chelation induced mitophagy for the treatment of Parkinson’s disease
… was to understand how the iron chelating drug, Deferiprone (DFP), mediates its effects in mitophagy through Parkin/PINK1 independent mechanisms. DFP is an iron chelating drug currently in clinical trials for the treatment of Parkinson’s disease and has been shown to induce mitophagy …
-
Hinokitiol restores hemoglobinization and mitigates neurodegeneration in animals by re-establishing iron homeostasis
… mediated by an FDA-approved iron chelator deferiprone (DFP) can lead to cellular iron deficiency, leading to perturbation of neuronal homeostasis. These results not only establish that iron homeostasis is essential for proper neural functioning, but they also suggest a unique alternative to …
-
Ironing out the pathophysiology of neurodegeneration with brain iron accumulation (NBIA) : clinical investigations and disease modelling yield novel evidence of systemic dysfunction and provide a robust and accurate disease model of NBIA
… PLAN, 37 weeks of therapy with the iron chelator deferiprone (DFP) as well as 20 months of therapy with the antioxidants alpha lipoic acid (ALA) and n-acetylcysteine (NAC) were efficacious in reducing the systemic oxidative and inflammatory disease burden, but it did not significantly alter the …
-
Development of a 3D printed particle embedded hydrogel mesh for localized delivery of iron-chelating agents
… intracellular iron hence induce apoptosis. Deferiprone (DFP) is amongst the most studied anti-cancer drugs with the ability to bypass the BBB and also be used to excrete the excess iron form the body. However, prolonged oral administration of this drug can be dangerous, which causes common …
-
Μελέτη του ρόλου του σιδήρου και αξιολόγηση της προστατευτικής ικανότητας σιδηροδεσμευτικών σκευασμάτων με διαφορετική λιποφιλικότητα στην ηπατική βλάβη από ισχαιμία-επαναιμάτωση: πειραματική μελέτη
… drugs, namely desferrioxamine (DFO) and deferiprone (DFP). The DFO-iron complexes are kinetically favored compared to DFP-iron ones. At the same time, DFP exhibits higher lipophilicity and lower molecular weight and is therefore more capable to penetrate through cell membranes and chelate …
-
Συμβολή στην μελέτη πρόσθιου και οπίσθιου λαβύρινθου σε ασθενείς με β-μεσογειακή αναιμία
… that the combination of deferoxamine withdeferiprone.6th) we identified simple equations that allow us to adjust the dose of administration of chelation agentsin patients who have managed to achieve a good degree of chelation, in order to continue to be in goodchelation condition and have …